OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer - Aprepitant

OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer

Browse by Cancer Type or Cancer Drug

		OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer > Blogs > admin
Aprepitant

Connect with Facebook

Mark Forums Read

Resource & Link Directory

Aprepitant

Old

Province approves cancer drugs

Posted 04-14-2009 at 08:14 PM by admin

Fri. Jan 30 - 5:25 AM

Nova Scotia has approved funding for a new treatment for advanced kidney cancer and two other drugs to lessen the side effects of treatment for some patients.

The province is one of the first in Canada to approve Torisel, which is the only existing treatment for a form of advanced kidney cancer that affects about 15 per cent of people with kidney cancer, manufacturer Wyeth Canada said in a release.

Patients with incurable kidney cancer...

Continue reading...

admin

Administrator

Posted in Aprepitant, Emend (Aprepitant), Politics and Cancer

Comments 0 admin is offline

admin is offline

Old

FDA Safety Changes: Boniva, Emend, Clozaril

Posted 04-14-2009 at 08:13 PM by admin

Yael Waknine

February 25, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for upper gastrointestinal tract effects and hypocalcemia in patients receiving ibandronate sodium, the need for back-up oral contraceptive measures during and after aprepitant therapy, and drug interactions with clozapine that can decrease therapeutic efficacy and increase the risk for adverse events.

Ibandronate (Boniva) Linked to Risk...

Continue reading...

admin

Administrator

Posted in Aprepitant, Emend (Aprepitant)

Comments 0 admin is offline

admin is offline

admin

admin is offline

Join Date Jul 2008
Posts 1,340
Blog Entries 1,492

Blog Categories

Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) (2)
Adrenocortical Carcinoma (4)
Adriamycin (Doxorubicin Hydrochloride) (16)
Adrucil (Fluorouracil) (12)
Afinitor (Everolimus) (2)
Aldara (Imiquimod) (4)
Alemtuzumab (3)
Alimta (Pemetrexed Disodium) (8)
Aminolevulinic Acid (2)
Anal Cancer (12)
Anastrozole (5)
Aprepitant (2)
Arimidex (Anastrozole) (5)
Aromasin (Exemestane) (4)
Arranon (Nelarabine) (1)
Arsenic Trioxide (2)
Avastin (Bevacizumab) (45)
Azacitidine (4)
Basal Cell Carcinoma (9)
Bendamustine Hydrochloride (3)
Bevacizumab (45)
Bexarotene (1)
Bexxar (Tositumomab) (1)
Bladder Cancer (34)
Bortezomib (14)
Brain and Spinal Cord Tumors (7)
Brain Stem Glioma (3)
Brain Tumor (91)
Breast Cancer (268)
Breast Cancer and Pregnancy (4)
Bronchial Tumors (1)
Burkitt Lymphoma (4)
Business (17)
Campath (Alemtuzumab) (3)
Camptosar (Irinotecan Hydrochloride) (7)
Capecitabine (20)
Carboplatin (14)
Carcinoid Tumor (2)
Carcinoma of Unknown Primary (3)
Celebrities and Cancer (44)
Central Nervous System Atypical Teratoid/Rhabdoid Tumor (6)
Central Nervous System Embryonal Tumors (11)
Cerebellar Astrocytoma (4)
Cerebral Astrocytoma/Malignant Glioma (10)
Cervical Cancer (44)
Cetuximab (19)
Childhood Cancer (79)
Chordoma (1)
Chronic Myeloproliferative Disorders (2)
Cisplatin (22)
Clofarabine (4)
Clolar (Clofarabine) (4)
Colon Cancer (109)
Colorectal Cancer (100)
Cutaneous T-Cell Lymphoma (6)
Cyclophosphamide (20)
Cytarabine (5)
Cytosar-U (Cytarabine) (5)
Cytoxan (Cyclophosphamide) (20)
Dacogen (Decitabine) (2)
Dasatinib (9)
Decitabine (2)
Degarelix for Injection (3)
DepoCyt (Liposomal Cytarabine) (1)
DepoFoam (Liposomal Cytarabine) (1)
Dexrazoxane Hydrochloride (1)
Docetaxel (23)
Doxil (Doxorubicin Hydrochloride Liposome) (6)
Doxorubicin Hydrochloride (16)
Doxorubicin Hydrochloride Liposome (6)
Efudex (Fluorouracil) (12)
Eligard (Leuprolide Acetate) (3)
Ellence (Epirubicin Hydrochloride) (5)
Eloxatin (Oxaliplatin) (11)
Emend (Aprepitant) (2)
Endometrial (Uterine) Cancer (24)
Ependymoblastoma (2)
Ependymoma (2)
Epirubicin Hydrochloride (5)
Erbitux (Cetuximab) (19)
Erlotinib Hydrochloride (18)
Esophageal Cancer (22)
Esthesioneuroblastoma (1)
Etoposide (4)
Everolimus (2)
Evista (Raloxifene Hydrochloride) (2)
Ewing Family of Tumors (11)
Exemestane (4)
Extracranial Germ Cell Tumor (2)
Extragonadal Germ Cell Tumor (1)
Extrahepatic Bile Duct Cancer (9)
Faslodex (Fulvestrant) (2)
Femara (Letrozole) (6)
Fludara (Fludarabine Phosphate) (9)
Fludarabine Phosphate (9)
Fluoroplex (Fluorouracil) (12)
Fluorouracil (13)
Fulvestrant (2)
Gallbladder Cancer (6)
Gardasil (Human Papillomavirus (HPV) Vaccine) (9)
Gastric (Stomach) Cancer (41)
Gastrointestinal Carcinoid Tumor (5)
Gefitinib (10)
Gemcitabine Hydrochloride (21)
Gemtuzumab Ozogamicin (1)
Gemzar (Gemcitabine Hydrochloride) (22)
Gestational Trophoblastic Tumor (2)
Gleevec (Imatinib Mesylate) (22)
Glioblastoma Multiforme (30)
Head and Neck Cancer (59)
Heart Tumors (2)
Herceptin (Trastuzumab) (23)
Human Papillomavirus (HPV) Vaccine (13)
Hycamtin (Topotecan Hydrochloride) (5)
Hypopharyngeal Cancer (8)
Ibritumomab Tiuxetan (3)
Imatinib Mesylate (22)
Imiquimod (4)
Intraocular (Eye) Melanoma (5)
Iressa (Gefitinib) (10)
Irinotecan Hydrochloride (7)
Islet Cell Tumors (Endocrine Pancreas) (5)
Ixabepilone (1)
Ixempra (Ixabepilone) (1)
Kaposi Sarcoma (5)
Kepivance (Palifermin) (1)
Lapatinib Ditosylate (8)
Laryngeal Cancer (22)
Lenalidomide (9)
Letrozole (6)
Leukemia (138)
Chronic Lymphocytic Leukemia (27)
Acute Lymphoblastic Leukemia (26)
Acute Myeloid Leukemia (34)
Acute Promyelocytic Leukemia (3)
Chronic Myelogenous Leukemia (23)
Hairy Cell Leukemia (2)
Leuprolide Acetate (3)
Levulan (Aminolevulinic Acid) (2)
Lip and Oral Cavity Cancer (38)
Liposomal Cytarabine (1)
Liver Cancer (52)
Lung Cancer (164)
Non-Small Cell Lung Cancer (58)
Small Cell Lung Cancer (9)
Lupron (Leuprolide Acetate) (3)
Lupron Depot (Leuprolide Acetate) (3)
Lupron Depot-Ped (Leuprolide Acetate) (3)
Lupron Depot-3 Month (Leuprolide Acetate) (3)
Lupron Depot-4 Month (Leuprolide Acetate) (3)
Lymphoma (95)
Non-Hodgkin Lymphoma (55)
Hodgkin Lymphoma (21)
Primary Central Nervous System Lymphoma (7)
Medulloblastoma (8)
Medulloepithelioma (1)
Merkel Cell Carcinoma (4)
Mesothelioma (Malignant) (23)
Metastatic Squamous Neck Cancer with Occult Primary (8)
Methotrexate (11)
Mozobil (Plerixafor) (1)
Multiple Endocrine Neoplasia Syndrome (1)
Multiple Myeloma (36)
Multiple Myeloma and Other Plasma Cell Neoplasms (7)
Mycosis Fungoides (1)
Myelodysplastic Syndromes (8)
Myelodysplastic/Myeloproliferative Diseases (4)
Mylosar (Azacitidine) (3)
Mylotarg (Gemtuzumab Ozogamicin) (1)
Nasopharyngeal Cancer (11)
Nelarabine (1)
Neuroblastoma (15)
Nexavar (Sorafenib Tosylate) (19)
Nilotinib (10)
Nolvadex (Tamoxifen Citrate) (16)
Nutrition and Cancer (78)
Oncaspar (Pegaspargase) (1)
Oral Cancer (31)
Oropharyngeal Cancer (22)
Osteosarcoma and Malignant Fibrous Histiocytoma of Bone (20)
Ovarian Cancer (82)
Oxaliplatin (11)
Paclitaxel (26)
Paclitaxel Albumin-stabilized Nanoparticle Formulation (2)
Palifermin (1)
Pancreatic Cancer (78)
Panitumumab (5)
Paranasal Sinus and Nasal Cavity Cancer (11)
Paraplatin (Carboplatin) (14)
Parathyroid Cancer (2)
Pegaspargase (1)
Pemetrexed Disodium (8)
Penile Cancer (6)
Pharyngeal Cancer (5)
Pheochromocytoma (1)
Pineal Parenchymal Tumors of Intermediate Differentiation (1)
Pineoblastoma (2)
Pituitary Tumor (2)
Platinol (Cisplatin) (22)
Platinol-AQ (Cisplatin) (21)
Pleuropulmonary Blastoma (1)
Plerixafor (1)
Politicians and Cancer (14)
Politics and Cancer (44)
Prostate Cancer (148)
Raloxifene Hydrochloride (2)
Rectal Cancer (44)
Renal Cell (Kidney) Cancer (49)
Research and Technology (295)
Respiratory Tract Carcinoma Involving the NUT Gene on Chromosome 15 (1)
Retinoblastoma (Eye Cancer) (8)
Revlimid (Lenalidomide) (9)
Rhabdomyosarcoma (6)
Rheumatrex (Methotrexate) (10)
Rituxan (Rituximab) (14)
Rituximab (14)
Salivary Gland Cancer (7)
Sézary Syndrome (1)
Skin Cancer (90)
Melanoma (64)
Nonmelanoma (11)
Small Intestine Cancer (1)
Soft Tissue Sarcoma (29)
Gastrointestinal Stromal Tumor (GIST) (12)
Sorafenib Tosylate (19)
Sprycel (Dasatinib) (9)
Squamous Cell Carcinoma (34)
Statistics (129)
Sunitinib Malate (19)
Supratentorial Primitive Neuroectodermal Tumors (3)
Sutent (Sunitinib Malate) (19)
Tabloid (Thioguanine) (1)
Tamoxifen Citrate (16)
Tarceva (Erlotinib Hydrochloride) (18)
Targretin (Bexarotene) (1)
Tasigna (Nilotinib) (10)
Taxol (Paclitaxel) (26)
Taxotere (Docetaxel) (23)
Temodar (Temozolomide) (6)
Temozolomide (6)
Temsirolimus (5)
Testicular Cancer (14)
Thalidomide (7)
Thalomid (Thalidomide) (7)
Thioguanine (1)
Throat (Pharyngeal) Cancer (25)
Thymoma and Thymic Carcinoma (1)
Thyroid Cancer (24)
Topotecan Hydrochloride (5)
Torisel (Temsirolimus) (5)
Tositumomab (1)
Totect (Dexrazoxane Hydrochloride) (1)
Transitional Cell Cancer of the Renal Pelvis and Ureter (5)
Trastuzumab (23)
Treanda (Bendamustine Hydrochloride) (3)
Trisenox (Arsenic Trioxide) (2)
Tykerb (Lapatinib Ditosylate) (8)
Urethral Cancer (3)
Uterine Sarcoma (3)
Vaginal Cancer (6)
Vectibix (Panitumumab) (5)
Velcade (Bortezomib) (14)
VePesid (Etoposide) (4)
Vidaza (Azacitidine) (4)
Vincasar PFS (5)
Vincristine (5)
Visual Pathway and Hypothalamic Glioma (2)
Vorinostat (1)
Vulvar Cancer (7)
Waldenström Macroglobulinemia (4)
Wilms Tumor and Other Childhood Kidney Tumors (3)
Women and Cancer (136)
Xeloda (Capecitabine) (21)
Zevalin (Ibritumomab Tiuxetan) (3)
Zinecard (Dexrazoxane Hydrochloride) (1)
Zoledronic Acid (5)
Zolinza (Vorinostat) (1)
Zometa (Zoledronic Acid) (5)

Recent Comments

Lapatinib Could Be Beneficial In Treating Patients With Aggressive Inflammatory BC by gpawelski

All times are GMT. The time now is 07:34 PM.